In mesothelioma, Creaney et al. recently demonstrated through comprehensive genomic analysis and tumor immune profiling that overexpression of TGFB1 contributed to the immunosuppressive microenvironment and was associated with worse survival in MESO [26]. The gene discussed is TGFB1; the disease is neoplasm.